Evogene (EVGN) Tops Q1 EPS by 35c
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.38), $0.35 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $2.44 million versus the consensus estimate of $4 million.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Bogota Financial Corp. (BSBK) Reports Q2 EPS of $0.06
- Quince Therapeutics (QNCX) files for 15.47M share offering by selling stockholders
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
